General Information of the Compound
Compound ID
CP0316986
Compound Name
2-[1-(4-cyanophenyl)piperidin-4-yl]-1H-1,3-benzodiazole-4-carboxamide
    Show/Hide
Structure
Formula
C20H19N5O
Molecular Weight
345.406
Canonical SMILES
NC(=O)c1cccc2nc([nH]c12)C1CCN(CC1)c1ccc(cc1)C#N
    Show/Hide
InChI
InChI=1S/C20H19N5O/c21-12-13-4-6-15(7-5-13)25-10-8-14(9-11-25)20-23-17-3-1-2-16(19(22)26)18(17)24-20/h1-7,14H,8-11H2,(H2,22,26)(H,23,24)
    Show/Hide
InChIKey
VZMBLEKOYWPSPQ-UHFFFAOYSA-N
Physicochemical Property
logP
2.91748
Rotatable Bonds
3
Heavy Atom Count
26
Polar Areas
98.8
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
4
Complexity
26

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 25190736
ChEMBL ID
CHEMBL459853
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00839, Poly [ADP-ribose] polymerase 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000337 C-4-I Homo sapiens (Human)  1
1
EC50 = 21 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki = 3 nM